A Study of [¹⁴C]-LY3202626 in Healthy Male Participants
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/21/2016 |
| Start Date: | September 2015 |
| End Date: | November 2015 |
Disposition of [¹⁴C]-LY3202626 Following Oral Administration in Healthy Male Subjects
The purpose of this study is to measure how much of the specially prepared study drug,
LY3202626, containing radiolabeled carbon [¹⁴C] gets into the blood stream and how long it
takes the body to get rid of it.
Information about any side effects that may occur will also be collected.
Participants will stay at a clinical research unit (CRU). The study will last about 28 days
(check in to follow-up) for each participant.
This study is for research purposes only and is not intended to treat any medical condition.
LY3202626, containing radiolabeled carbon [¹⁴C] gets into the blood stream and how long it
takes the body to get rid of it.
Information about any side effects that may occur will also be collected.
Participants will stay at a clinical research unit (CRU). The study will last about 28 days
(check in to follow-up) for each participant.
This study is for research purposes only and is not intended to treat any medical condition.
Inclusion Criteria:
- Are overtly healthy males, as determined by physical examination, clinical laboratory
tests, medical history and electrocardiogram (ECG)
- Have a body mass index (BMI) of 18.5 to 32.0 kilograms per meter squared (kg/m²)
inclusive at screening
Exclusion Criteria:
- Have participated in a [¹⁴C]-study within the last 6 months prior to admission for
this study
- Regularly use known drugs of abuse and/or show positive findings on urinary drug
screening
- Have consumed grapefruits or grapefruit-containing products, Seville oranges or
Seville orange-containing products, star fruits or star fruit-containing products
within 7 days prior to dosing or intend to consume during the study
- Have a history of constipation or have had acute constipation within 3 weeks prior to
admission
- Are currently or have been smokers or users of tobacco or nicotine replacement
products within the 3 months prior to admission and/or have positive cotinine at
screening or check-in
- Exposure to significant diagnostic, therapeutic, or employment-related radiation
within 12 months prior to dosing (e.g., serial x-ray or computed tomography scans,
barium meal, current employment in a job requiring radiation exposure monitoring)
We found this trial at
1
site
Click here to add this to my saved trials
